EnJun Yang

Company: Parker Institute for Cancer Immunotherapy

Job title: Research Director

Seminars:

Fireside Chat: Leveraging the Predictive Power of Liquid Biopsy for IO Treatment Response Monitoring 12:30 pm

Challenges with treatment response monitoring today Enhancing the predictive power of liquid biopsy with a methylation-based approach to treatment response monitoring  Learn about Guardant / PICI’s new data, showcasing clinical evidence behind methylation-based tumor fraction for IO response monitoring Hear how response monitoring using liquid biopsy can accelerate drug developmentRead more

day: Day One